These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29023184)

  • 21. Mechanisms of prion-induced neurodegeneration.
    Saá P; Harris DA; Cervenakova L
    Expert Rev Mol Med; 2016 Apr; 18():e5. PubMed ID: 27055367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propagation of the prion phenomenon: beyond the seeding principle.
    Münch C; Bertolotti A
    J Mol Biol; 2012 Aug; 421(4-5):491-8. PubMed ID: 22245492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid associated proteins in Alzheimer's and prion disease.
    Veerhuis R; Boshuizen RS; Familian A
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):235-48. PubMed ID: 15975027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of activity in synaptic degeneration in a protein misfolding disease, prion disease.
    Caleo M; Restani L; Vannini E; Siskova Z; Al-Malki H; Morgan R; O'Connor V; Perry VH
    PLoS One; 2012; 7(7):e41182. PubMed ID: 22815961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglia in prion diseases.
    Aguzzi A; Zhu C
    J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The propagation of prion-like protein inclusions in neurodegenerative diseases.
    Goedert M; Clavaguera F; Tolnay M
    Trends Neurosci; 2010 Jul; 33(7):317-25. PubMed ID: 20493564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A neuroprotective role for microglia in prion diseases.
    Zhu C; Herrmann US; Falsig J; Abakumova I; Nuvolone M; Schwarz P; Frauenknecht K; Rushing EJ; Aguzzi A
    J Exp Med; 2016 May; 213(6):1047-59. PubMed ID: 27185853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases.
    Yoshida S; Hasegawa T
    Neurochem Int; 2022 May; 155():105307. PubMed ID: 35181393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein.
    Jackson WS
    Dis Model Mech; 2014 Jan; 7(1):21-9. PubMed ID: 24396151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion and prion-like diseases in animals.
    Aguilar-Calvo P; García C; Espinosa JC; Andreoletti O; Torres JM
    Virus Res; 2015 Sep; 207():82-93. PubMed ID: 25444937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time.
    Muth C; Schröck K; Madore C; Hartmann K; Fanek Z; Butovsky O; Glatzel M; Krasemann S
    Brain Pathol; 2017 Sep; 27(5):590-602. PubMed ID: 27558169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining the Protein Seeds of Neurodegeneration using Real-Time Quaking-Induced Conversion Assays.
    Manca M; Kraus A
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32854212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into Mechanisms of Chronic Neurodegeneration.
    Diack AB; Alibhai JD; Barron R; Bradford B; Piccardo P; Manson JC
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70).
    Mays CE; Armijo E; Morales R; Kramm C; Flores A; Tiwari A; Bian J; Telling GC; Pandita TK; Hunt CR; Soto C
    J Biol Chem; 2019 Sep; 294(37):13619-13628. PubMed ID: 31320473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype.
    Pankiewicz JE; Lizińczyk AM; Franco LA; Diaz JR; Martá-Ariza M; Sadowski MJ
    Acta Neuropathol Commun; 2021 Sep; 9(1):157. PubMed ID: 34565486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is loss of function of the prion protein the cause of prion disorders?
    Hetz C; Maundrell K; Soto C
    Trends Mol Med; 2003 Jun; 9(6):237-43. PubMed ID: 12829011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.